-
265241-1GPurity Limit: &ge 99% (TLC) Molecular Formula: C12H15NO2·HCl Molecular Weight: 241.72 MDL No.
-
265241-250MGPurity Limit: &ge 99% (TLC) Molecular Formula: C12H15NO2·HCl Molecular Weight: 241.72 MDL No.
-
265241-25MGPurity Limit: &ge 99% (TLC) Molecular Formula: C12H15NO2·HCl Molecular Weight: 241.72 MDL No.
-
265241-5GPurity Limit: &ge 99% (TLC) Molecular Formula: C12H15NO2·HCl Molecular Weight: 241.72 MDL No.
-
18528-1A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
18528-10A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
18528-25A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
18528-5A bacterial DNA gyrase inhibitor that disrupts supercoiling activity (IC<sub>50</sub> = 3.3 µM) demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs range from 10-80 µM).
-
16794-100An enantiomer of ibuprofen that does not inhibit COX inhibits NF-&kappaB activation (IC<sub>50</sub> = 121.8 µM) in response to T-cell stimulation blocks superoxide formation, &beta-glucuronidase release, and LTB4 generation by stimulated
-
16794-250An enantiomer of ibuprofen that does not inhibit COX inhibits NF-&kappaB activation (IC<sub>50</sub> = 121.8 µM) in response to T-cell stimulation blocks superoxide formation, &beta-glucuronidase release, and LTB4 generation by stimulated
-
16794-500An enantiomer of ibuprofen that does not inhibit COX inhibits NF-&kappaB activation (IC<sub>50</sub> = 121.8 µM) in response to T-cell stimulation blocks superoxide formation, &beta-glucuronidase release, and LTB4 generation by stimulated
-
18235-10A pure enantiomer of lansoprazole that inhibits acid formation in isolated canine parietal cells with an IC<sub>50</sub> value of 59 nM and inhibits the H+/K+-ATPase with an IC<sub>50</sub> value of 4.2 µM.